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Abstract
Peroxisome development is a dynamic process that is not yet completely understood. We use the methylotrophic yeast Hansenula
polymorpha as model in our studies on peroxisome homeostasis. Cells of this species may contain different types of peroxisomes that differ
in protein composition and capacity to incorporate matrix proteins. This protein import machinery is highly flexible and can accommodate
unfolded and complex folded proteins.
D 2002 Published by Elsevier Science B.V.
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1. Introduction
Peroxisomes are ubiquitous cell organelles that strongly
vary in abundance and function [1,2]. In fungi, their function
ranges from a crucial role in penicillin biosynthesis to a
function in nematode capturing by certain nematophagous
fungi [3] or sealing septal pores in hyphae [4]. The reason as
to why these organelles have gained such different functions
in various organisms is fully unclear. Characteristic for
peroxisomes is their extremely high matrix/membrane pro-
tein ratio. The low abundance of large integral membrane
proteins in peroxisomes of the yeast Hansenula polymorpha
is convincingly illustrated by the typical smooth fractures
faces of the peroxisomal membrane in freeze etch replicas [5].
In recent years, much has been learned on the protein
components that are essential for peroxisome biogenesis.
Many of these proteins, termed peroxins, have been identi-
fied by functional complementation of yeast mutants, defi-
cient in peroxisome biogenesis (pex mutants). Various
components involved in matrix protein import, membrane
biogenesis, organelle fission and movement have been
identified and the first details on their molecular functions
are emerging. However, several controversial topics have
been discerned, the solution of which is essential for the
progress in the field, and which is topic of discussion in this
paper.
2. Peroxisome development
In normal wild-type cells, peroxisomes multiply by divi-
sion. The first clear cut examples of peroxisome division as a
mode to supply developing cells (buds) with new organelles
have been described in yeast [6]. Later, Lazarow and Fujiki
[7] provided biochemical evidence for this mode of perox-
isome proliferation. Remarkably, morphological evidence
for peroxisome fusion events, comparable to for instance
vacuole and mitochondrial compartments, has not been
reported yet. In addition, fusion of mature peroxisomes
seems unlikely as huge organelles, resulting from this, have
never been observed in yeast cells. The only example known
in the yeast H. polymorpha resulted from the overexpession
of alcohol oxidase (AO) protein in a mutant strain of this
yeast species [8]. Large peroxisomes have also been
observed in other yeast species defective in the peroxin
Pex11p [9,10]. Most likely, this is due to a failure in fusion
instead of being a result of fusion. Normally, the organelles
are quite comparable of size, giving support to the notion that
growth by matrix protein import may cease at a certain stage
of development or alternately, that the putative removal of
waste proteins and new protein uptake are at a state of
equilibrium. However, we have obtained evidence that
peroxisomes in methylotrophic yeast are only temporally
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matrix protein import competent [11] and showed that import
was in fact confined to few small organelles that were present
in the cells. This implies that the cells contain different
classes of peroxisomes, namely mature organelles that appa-
rently have lost the capacity to incorporate matrix proteins
(and thus can be considered ‘‘enzyme bags’’) and a minor
number of small organelles that can grow and multiply.
However, several questions remain that require an unequiv-
ocal answer:
(i) Is the above mode of peroxisome development con-
served or only valid for methylotrophic yeast species?
(ii) Is the capacity to import matrix proteins donated from
one organelle to another [12] or are organelles contin-
uously (one after the other) formed from specific or-
ganelles or a peroxisome reticulum?
(iii) What is the molecular basis for the discrimination
between import competent and incompetent organel-
les?
(iv) Do alternative modes of peroxisome biogenesis exist?
3. Alternative modes of peroxisome formation
Titorenko et al. [2,13,14] were the first to provide clear-
cut evidence that peroxisome development in Y. lipolytica
involves membrane fusion events. These workers demon-
strated that peroxisomes develop by a multistep process that
initiates with the formation of preperoxisomal vesicles that
arise from a subdomain of the ER. These structures harbour
distinct subsets of membrane proteins as well as compo-
nents of COPII vesicles and transform into early peroxiso-
mal precursors, designated P1 and P2, as a result of the
uptake of additional membrane proteins and release of the
COPII elements. P1 and P2 peroxisomes are competent to
incorporate distinct sets of matrix proteins and fuse in a
Pex1p/Pex6p dependent way to generate P3 peroxisomes
that develop into mature peroxisomes by a multistep assem-
bly pathway via P4 and P5 peroxisomes. Also in perox-
isome-deficient human fibroblasts, evidence was obtained
for a multistep peroxisome assembly pathway that occurred
upon reintroduction of PEX16 in cells of a Pex16p-defective
cell line [15]. In this system, Pex16p is incorporated in a
preperoxisome, followed by the insertion of other PMPs that
enables subsequent matrix protein import. These preperox-
isomes are autonomous structures that do not arise from the
ER and assemble into nascent peroxisomes independent of
COP proteins [16] or the ER translocon [17].
We showed that in H. polymorpha pex3 cells the endo-
membrane system may serve as template for the formation
of new peroxisomes [18]. Upon synthesis of the initial 50
amino acids of Pex3p (N50.Pex3p) in H. polymorpha pex3,
various vesicles were formed that arose from the nuclear
envelope. These vesicles showed peroxisomal character-
istics and contained, apart from N50.Pex3p, other peroxiso-
mal membrane proteins. Upon subsequent synthesis of full-
length Pex3p, a portion of these vesicles developed into
normal peroxisomal peroxisomes.
In concept, the models proposed for Y. lipolytica and H.
polymorpha pex3 display comparable properties as they
suggest that (re-)introduction of peroxisomes initiates at
the endomembrane system. However, the Y. lipolytica model
proposes that this pathway occurs in WT cells upon induc-
tion of peroxisome formation. The reintroduction models
explain how peroxisomes assemble in cells that were fully
devoid of peroxisomes due to genetic defects. It is unclear
yet whether such a mechanism is also operative in cells that
grow normally at peroxisome-inducing conditions. In H.
polymorpha, the ‘normal’ pathway of growth and division
became operative upon prolonged cultivation in cells in
which peroxisome formation initially was started by
N50.Pex3p-induced vesicles. Thus, in this organism, the
above mechanism of peroxisome recovery may represent a
rescue mechanism that becomes functional in case perox-
isomes are lost, e.g. due to failure in inheritance.
4. Matrix protein import
The matrix protein import machinery is remarkably
conserved in low and higher eukaryotes. For these proteins,
two peroxisomal targeting signals (PTS1 and PTS2) are
detected that are recognized by the cytosolic receptors
Pex5p and Pex7p, respectively. Both receptors bind their
cargo proteins in the cytosol and guide them to a docking
site at the peroxisomal membrane. Dammai and Subramani
[19] recently presented evidence that human Pex5p in fact is
a cycling receptor, which translocates across the peroxiso-
mal membrane bound to a PTS1-cargo protein and, follow-
ing release of its cargo, cycles back to the cytosol. This so-
called ‘‘extended shuttle model’’ was first proposed for the
yeast H. polymorpha [12,20] and in human cell lines [21].
This finding has the major implication that (i) a protein
export machinery must exist for Pex5p and (ii) in case
Pex5p dissociates from the inner surface of the membrane, a
Pex5p sorting machinery exists in the organellar matrix.
Both aspects are yet completely unresolved. It is also not
known whether import and export require separate machi-
neries or use one and the same. In this context, it is tempting
to speculate that one of the peroxins proposed to function in
docking (e.g. Pex13p and Pex14p) in fact may function in
Pex5p export. Pex14p may represent a plausible candidate
as it is not essential for matrix protein import [22]. Blocking
Pex5p recycling would slow down matrix protein import to
a very low level, as in pex14 strains. This is in line with the
phenotype of the H. polymorpha pex4 mutant, which con-
tains peroxisomal remnants that contain AO protein [23].
Pex14p is also essential for selective peroxisome degrada-
tion in H. polymorpha. Bellu et al. [24] showed that the
information that governs the degradation process is located
in the extreme N-terminus of the protein. This means that
Pex14p may have multiple functions and act as a molecular
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switch that discriminates between two oppositely directed
processes namely organelle assembly and selective degra-
dation. Pex14p may also be—part of—the clue that deter-
mines the temporal import capacity of peroxisomes because
of a change in modification (phosphorylation [25,26]) or in
topology of the N-terminus.
The current models on PTS1 protein import generally
propose a single import pathway. However, as specific PTS1
proteins (e.g. acyl CoA oxidase [27]) are only imported as
oligomers, whereas import of AO is restricted to monomers
[28], this pathway may be much more versatile. It has to be
considered that the PTS1 pathway may exist as separate,
probably overlapping tracks. A plausible explanation for a
dynamic PTS1 matrix protein import machinery is that
delivery of the Pex5p-cargo complex at the peroxisomal
membrane is paralleled by the assembly of a docking
complex, followed by association of another subset of
peroxins into a dynamic translocation pore. Other com-
plexes may subsequently form that are involved in Pex5p
export/recycling. Specific complexes that mediate import of
folded and unfolded peptides may contain common ele-
ments [29], which explains the extensive network of pro-
tein–protein interactions that have been discovered among
peroxins involved in peroxisomal protein import.
5. Assembly of octameric, FAD-containing AO
It has been demonstrated that several peroxisomal matrix
proteins are imported into peroxisomes as folded, oligo-
meric structures. In this respect, AO of methylotrophic
yeasts seems to be an exception on this rule. The import
and assembly of H. polymorpha AO has been topic of
investigation for over 10 years. AO is an oligomeric enzyme
that consists of eight identical subunits that each contains an
FAD-molecule noncovalently bound. In WT cells, the activ-
ity of this enzyme is confined to the peroxisomal matrix,
and several lines of evidence have lend support to the view
that octamerisation occurs inside the organelle upon import
of inactive monomers.
Several independent approaches have revealed that octa-
meric AO cannot be transported across the peroxisomal
membrane [30,31], whereas other PTS1 proteins are
imported as oligomers in H. polymorpha peroxisomes [32].
Therefore, most likely, specific proteins are involved in AO
import/activation that are not required for other H. polymor-
pha PTS1 proteins. In order to identify such proteins, H.
polymorpha mutants were isolated that are blocked in AO
import and activation. These mutants display a strongly
reduced AO activity and, as a consequence, fail to grow on
methanol. Complementation analysis of the mutants avail-
able so far revealed the presence of 10 different comple-
mentation groups [33]. One of these groups has been studied
in detail. These mutants are characterised by accumulation of
inactive, FAD-lacking monomeric AO in the cytosol while
other peroxisomal matrix proteins are normally activated and
sorted to peroxisomes. The gene that functionally comple-
mented the AO-assembly defective phenotype in this group
of mutants encodes the enzyme pyruvate carboxylase
(HpPyc1p). Pyruvate carboxylase is an anapleurotic enzyme,
localised in the cytosol, that replenishes the tricarboxylic
acid cycle by the synthesis of oxaloacetate. Mutational
analyses revealed that not HpPyc1p enzyme activity, but
the protein was essential to functionally complement the AO
assembly defect in these mutants. Hence, HpPyc1p fulfils a
dual role in that, besides its well-characterised metabolic
function as anapleurotic enzyme, the protein plays a specific
role in the AO sorting and assembly. Because FAD-lacking
AO monomers accumulate in the absence of HpPyc1, it is
tempting to speculate that HpPyc1p mediates FAD-binding
to AO monomers in the cytosol. Previous studies using an H.
polymorpha riboflavin-deficient mutant (rif1) already indi-
cated that FAD-binding is essential to allow efficient import
and octamerisation of AO [34,35]. Most likely, newly
synthesised AO monomers first bind FAD, mediated by
HpPyc1p, followed by binding to the PTS1 receptor Pex5p.
Then, FAD-containing monomers bound to Pex5p are taken
up by the organelles followed by dissociation of Pex5p. This
allows the FAD-containing monomers to oligomerise into
the enzymatically active octamers, a process that most likely
occurs spontaneously [36].
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